Grace Therapeutics
GRCE
10 hedge funds and large institutions have $24.9K invested in Grace Therapeutics in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
11% more funds holding
Funds holding: 9 → 10 (+1)
0.02% less ownership
Funds ownership: 0.03% → 0.02% (-0.02%)
53% less capital invested
Capital invested by funds: $53.1K → $24.9K (-$28.2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$7.43K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$295 |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$124 |
| 4 |
MCC
Money Concepts Capital
Palm Beach Gardens,
Florida
|
+$91 |
| 5 |
BlackRock
New York
|
+$29 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$14K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$10K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $9K | – | – | – |
|
|
2
National Bank of Canada
Montreal,
Quebec, Canada
| $8.86K | +$7.43K | +2,521 | +459% |
|
3
Morgan Stanley
New York
| $5.66K | – | – | – |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$295 | +100 | +54% |
|
|
ASN
5
Advisory Services Network
Atlanta,
Georgia
| $125 | +$124 | +42 | New |
|
|
MCC
6
Money Concepts Capital
Palm Beach Gardens,
Florida
| $94 | +$91 | +31 | New |
|
|
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $89 | – | – | – |
|
|
8
BlackRock
New York
| $31 | +$29 | +10 | New |
|
|
IGWM
9
ICA Group Wealth Management
Denver,
Colorado
| $29 | +$29 | +10 | New |
|
|
TWC
10
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $3 | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$14K | -4,048 | Closed |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$10K | -2,971 | Closed |
|
|
TSS
13
Two Sigma Securities
New York
| – | -$10K | -2,823 | Closed |
|
GRCE Hedge Fund Activity: Q4 2022 in Review
10 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q4 2022, worth a combined $24.9K — down 53% from $53.1K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GRCE positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was National Bank of Canada, adding an estimated $7.43K. The largest seller was UBS Group, exiting entirely with an estimated $14K sold.
- 10 institutional investors held Grace Therapeutics (GRCE) as of Q4 2022, up from 9 in Q3 2022.
- Funds reported $24.9K of Grace Therapeutics stock for Q4 2022, down 53% quarter-over-quarter.
- 4 funds opened new Grace Therapeutics positions in Q4 2022 and 3 closed out, a net change of +1 holder.
- The largest Grace Therapeutics buyer in Q4 2022 was National Bank of Canada, an estimated $7.43K added.
- The largest Grace Therapeutics seller in Q4 2022 was UBS Group, an estimated $14K sold.
Based on aggregated 13F filings for Q4 2022.